NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (LUCD) (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned ...
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI.
SAN RAMON, Calif.--(BUSINESS WIRE)--Halteres Associates today announced the launch of their new “It’s Not Magic, It’s Diagnostics” website, a resource developed by the firm to advocate for the ...
New Website Provides Essential Information on Company's Strategic Initiative TORONTO, Feb. 18, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSX-V: SQD) (OTCQB: SQIDF), a ...
SPOKANE, Wash., May 20, 2022 /PRNewswire/ -- Leading provider of digital pathology solutions, Gestalt Diagnostics, Inc today announces the re-launch of its website with embedded user-triggered ...
The live and archived webcast of the fireside chat can be accessed by clicking here or by visiting the Investor Relations Section of the Lucid Diagnostics website. A replay of the webcast will be ...
WOIPPY, MOSELLE, FRANCE, January 27, 2026 /EINPresswire.com/ — ABL Diagnostics (FR001400AHX6) (“ABLD” or the “Company”) announces that All Invest Securities ...
Cardio Diagnostics' redesigned website, CDIO.AI, highlights three core solutions, among others, which exemplify the Company's AI-driven approach to cardiovascular care. The Epi+Gen CHD test is an ...
TORONTO, Feb. 18, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSX-V: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results